CMV is a virus that can infect people of all ages, and most people have no symptoms. When a baby is born with CMV infection, it is called congenital CMV. About one out of every 200 babies is born with congenital CMV infection. About one in five babies with congenital CMV infection will have long-term health problems. Screening for CMV in certain newborns is required by law.
This page has information and resources for partners who work on lead poisoning. This includes home visitors, partners funded to provide community-based lead poisoning prevention programs, and people who serve on the Lead Poisoning Prevention Advisory Board.
Manufacturers or importers into the United States who sell 1,800 gallons or more of paint in Maine in a calendar year are required to pay 25 cents per gallon of paint sold in Maine for that year.
Health care providers approved to perform in-office blood lead testing must report results from all in-office blood lead tests directly to the Maine Childhood Lead Poisoning Prevention Program (CLPPP). Reports must be complete, timely, legible and submitted within 48 hours of the test.
The Childhood Lead Poisoning Prevention Program uses blood lead test results to monitor public health and plan, evaluate, and target resources for lead poisoning prevention activities. We use all results, even those below 5 ug/dL, for these purposes.
Follow Maine CDC guidelines and test all children for lead poisoning at 1 and 2 years of age. Effective October 1, 2022, providers should confirm all capillary blood lead levels 3.5 ug/dL or higher with venous samples.
The Maine Immunization Information System (ImmPact) is a statewide system that stores electronic immunization records. ImmPact combines the vaccines a person has received into a single record, even if they were given by different health care providers in the state.
The only approved method of reporting point of care testing results is through the ImmPact Blood Lead Module.
